SAGE THERAPEUTICS INC (SAGE)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$9
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $9 | 1 | 0.00% | 15q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $9 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $9 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 2 | $469 | 22,221 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 4 | $39.4K | 26,711 | 0 | 1 | 1 | 0.0% |
| Q2 2025 | 179 | $449.3M | 48,052,603 | 35 | 55 | 52 | 2.5% |
| Q1 2025 | 185 | $413.5M | 51,493,524 | 54 | 47 | 46 | 1.0% |
| Q4 2024 | 162 | $266.8M | 48,500,793 | 18 | 45 | 53 | 1.3% |
| Q3 2024 | 162 | $366.5M | 49,967,269 | 11 | 61 | 46 | 1.2% |
| Q2 2024 | 181 | $595.9M | 53,900,148 | 29 | 69 | 51 | 1.9% |
| Q1 2024 | 185 | $1.2B | 61,006,432 | 23 | 62 | 52 | 0.7% |
| Q4 2023 | 182 | $1.3B | 57,850,372 | 23 | 41 | 64 | 1.6% |
| Q3 2023 | 178 | $1.2B | 58,235,336 | 29 | 74 | 41 | 2.0% |
| Q2 2023 | 197 | $2.4B | 50,135,943 | 21 | 64 | 65 | 1.6% |
| Q1 2023 | 186 | $2.3B | 55,156,490 | 29 | 58 | 44 | 1.0% |
| Q4 2022 | 164 | $1.7B | 42,894,433 | 27 | 46 | 47 | 1.6% |
| Q3 2022 | 199 | $2.1B | 52,342,394 | 22 | 59 | 60 | 1.4% |
| Q2 2022 | 202 | $1.7B | 51,082,018 | 36 | 57 | 68 | 1.9% |
| Q1 2022 | 205 | $1.7B | 49,947,001 | 31 | 65 | 75 | 3.0% |
| Q4 2021 | 210 | $2.2B | 50,375,953 | 16 | 71 | 70 | 4.5% |
| Q3 2021 | 225 | $2.2B | 49,073,950 | 30 | 83 | 65 | 2.2% |
| Q2 2021 | 263 | $3.1B | 50,665,856 | 42 | 97 | 77 | 6.0% |
| Q1 2021 | 265 | $4.1B | 53,089,301 | 53 | 76 | 86 | 3.5% |
| Q4 2020 | 252 | $4.8B | 53,977,114 | 42 | 68 | 81 | 2.7% |
| Q3 2020 | 232 | $3.4B | 53,657,303 | 38 | 70 | 73 | 2.6% |
| Q2 2020 | 217 | $2.3B | 54,275,646 | 46 | 79 | 52 | 2.3% |
| Q1 2020 | 230 | $1.7B | 56,339,051 | 50 | 80 | 66 | 1.7% |
| Q4 2019 | 274 | $4.3B | 56,623,315 | 44 | 96 | 72 | 5.5% |
| Q3 2019 | 288 | $8.5B | 58,644,240 | 43 | 96 | 85 | 2.7% |
| Q2 2019 | 278 | $11.1B | 58,207,903 | 40 | 91 | 80 | 3.8% |
| Q1 2019 | 277 | $9.3B | 56,856,837 | 58 | 127 | 60 | 3.0% |
| Q4 2018 | 254 | $5.0B | 50,238,634 | 2 | 6 | 7 | 4.4% |